Executive Team

Dr. Ambar Vaidya

President & Chief Executive Officer

• As a founder member, overall responsibility for Global Operations within PhaseON

• More than 20 years experience in Pharmaceutical Industry with over 18+ years in Clinical Research having done doctorate in Clinical Research and Masters in Business Development

• Instrumental in establishing operations for first largest global CRO in India. Worked with leading CROs like Quintiles, Lambda, Encorium Research and Accutest in the past

• Worked previously as a member of the board for global CROs in India and Hong Kong. Worked extensively in global leadership position with the teams in India, Latin America and in CEE region in the capacity as Project
Director for several Global-Multi Country studies in the past

• Key therapeutic experience: Oncology, CNS, Hematology, Respiratory, Dermatology, Gastroenterology, Infectious Diseases & Vaccines, Pediatrics, Pain Management, innovation device and also on Neutraceuticals products and OTC studies

• Associated as an honorary faculty and mentor to few of the reputed clinical research and management institutes in Ahmedabad and Mumbai

Itzigueri Robles

Director Operations, Latin America

• 15+ years of experience in Clinical Research

• Coordinates the Project Management team in Latin America (based out of Mexico)

• Previous experience as ICRO Manager for Novartis Pharma and Director of Operations for global CROs like   Quintiles and Encorium

• Excellent contacts within Regulatory authorities, particularly Mexico

• Established relationships with key investigator sites and key opinion leaders

• Key therapeutic experience: Infectious Diseases & Vaccines, Oncology, Hematology, Respiratory, CNS, CVS, Pain, Diabetes, Dermatology

Advisory Board

Dr. V Srivatsan

Consultant – Scientific Affairs

Dr. V Srivatsan is Doctorate in Organic Chemistry form Indian Institute of Sciences, Bangalore (IISc). and is associated with PhaseON Clinical Research as honorary advisor for scientific affairs and business strategies

He was associated as a Post Doc Associate in College of Pharmacy, University of Gorgia,Athens, USA, he moved back to India to work with Ranbaxy Ltd.

He was in senior leadership position for over a decade handling operations, business development and strategic organizational development. In his past assignments, he was one of the founder director in one of India's largest CRO - Lambda Therapeutic Research.

During his last assignment, he was Executive Director at Exceleris India. He currently works as a Consultant for Phase I-IV studies, Bioavailability, Bioequivalence, Pharmacokinetics and Bioanalytical studies.

Dr. Bhaswat S. Chakraborty

Former Senior Reviewer – Safety & Efficacy Review – CANADIAN FDA

Dr. Bhaswat S. Chakraborty is a PhD in Clinical Pharmacology from University of Saskatchewan, Saskatoon, Canada and is associated with PhaseON Clinical Research in the capacity of honorary advisor for scientific affairs

Dr. Chakraborty worked at the Health Protection Branch, Ministry of Health, Government of Canada (Canadian FDA) in Ottawa and served as a Senior Clinical Reviewer and Acting Department Head of the New Drug Applications. In this role, he has evaluated more than 300 Abbreviated New Drug Applications and 20 Pharmacokinetics based New Drug Applications.

He was the Director of Biopharmaceutics at Biovail Corporation International, Toronto. Till date, he has designed and investigated ~600 Phase I and 60 higher Phase Clinical Studies for the FDA, TPP, EU and other Agencies.

Recipient of many prestigious research grants, Dr. Chakraborty is also an author and co-author of more than 100 scientific papers and abstracts in refereed international journals.

He is an Honorary Professor and External Examiner to a few universities; editorial board member of three international journals; reviewer of many professional journal manuscripts, and also on the board of several Institutes and Universities in India and USA in various capacities.